Genscript Biotech Corporation (G51) — Free Cash Flow Generation Index
Genscript Biotech Corporation (G51) has a Free Cash Flow Generation Index of 1.00x as of December 2019. Free cash flow of €61.62 Million represents 1% of operating cash flow (€61.62 Million). See Genscript Biotech Corporation (G51) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Genscript Biotech Corporation Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Genscript Biotech Corporation across 5 annual periods. Explore G51 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Genscript Biotech Corporation (2016–2025)
Year-by-year Free Cash Flow Generation Index for Genscript Biotech Corporation. For the full company profile including market capitalisation, see G51 market cap overview.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.74x | €241.69 Million | €325.52 Million | €83.84 Million | ▲ +177.7% |
| 2024 | -0.96x | €-72.27 Million | €75.65 Million | €147.92 Million | ▼ -236.2% |
| 2018 | 0.70x | €215.80 Million | €307.66 Million | €70.84 Million | ▲ +241.4% |
| 2017 | -0.50x | €-10.60 Million | €21.37 Million | €29.21 Million | ▼ -139.1% |
| 2016 | 1.27x | €42.26 Million | €33.27 Million | €8.98 Million | — |